Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Perfusion Imaging | 3 | 2022 | 554 | 1.600 |
Why?
|
Psoriasis | 4 | 2023 | 898 | 1.440 |
Why?
|
Coronary Artery Disease | 6 | 2023 | 6487 | 1.220 |
Why?
|
Myocardial Ischemia | 3 | 2023 | 2148 | 1.170 |
Why?
|
Heart Auscultation | 2 | 2017 | 37 | 1.150 |
Why?
|
Arthritis, Rheumatoid | 5 | 2024 | 3712 | 0.980 |
Why?
|
Cardiovascular Diseases | 9 | 2024 | 15165 | 0.950 |
Why?
|
Colchicine | 2 | 2023 | 243 | 0.880 |
Why?
|
Systemic Vasculitis | 1 | 2023 | 37 | 0.860 |
Why?
|
Pericarditis | 1 | 2023 | 128 | 0.830 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2022 | 290 | 0.800 |
Why?
|
Heart Diseases | 3 | 2023 | 2788 | 0.760 |
Why?
|
Heart Injuries | 1 | 2021 | 210 | 0.710 |
Why?
|
Troponin T | 2 | 2021 | 754 | 0.690 |
Why?
|
Atherosclerosis | 3 | 2024 | 3445 | 0.670 |
Why?
|
Coronary Circulation | 5 | 2023 | 1572 | 0.660 |
Why?
|
Heart Sounds | 1 | 2017 | 20 | 0.600 |
Why?
|
Rheumatology | 1 | 2023 | 576 | 0.590 |
Why?
|
Rheumatic Diseases | 1 | 2023 | 592 | 0.580 |
Why?
|
Ventricular Dysfunction | 1 | 2017 | 143 | 0.550 |
Why?
|
Stethoscopes | 1 | 2015 | 28 | 0.530 |
Why?
|
Breast Feeding | 1 | 2023 | 1338 | 0.510 |
Why?
|
Skin Diseases | 1 | 2023 | 1065 | 0.490 |
Why?
|
Lupus Erythematosus, Systemic | 4 | 2021 | 2104 | 0.490 |
Why?
|
Heart | 2 | 2023 | 4467 | 0.450 |
Why?
|
Coronary Vessels | 2 | 2023 | 3107 | 0.450 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1573 | 0.440 |
Why?
|
Cardiovascular System | 1 | 2020 | 832 | 0.430 |
Why?
|
Ammonia | 2 | 2023 | 239 | 0.420 |
Why?
|
Inflammation | 7 | 2023 | 10638 | 0.400 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2356 | 0.400 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2011 | 49 | 0.400 |
Why?
|
Myocardium | 2 | 2021 | 4776 | 0.390 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1912 | 0.370 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1790 | 0.360 |
Why?
|
Peptide Fragments | 1 | 2021 | 5097 | 0.320 |
Why?
|
Tissue Donors | 1 | 2017 | 2240 | 0.320 |
Why?
|
Interleukin-6 | 3 | 2023 | 3200 | 0.290 |
Why?
|
Positron-Emission Tomography | 5 | 2023 | 6234 | 0.280 |
Why?
|
Cell Lineage | 2 | 2011 | 2504 | 0.260 |
Why?
|
Immunotherapy | 1 | 2020 | 4445 | 0.240 |
Why?
|
Heart Transplantation | 1 | 2017 | 3110 | 0.240 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11727 | 0.240 |
Why?
|
Echocardiography | 1 | 2015 | 5102 | 0.220 |
Why?
|
Humans | 37 | 2024 | 744343 | 0.220 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3229 | 0.210 |
Why?
|
Janus Kinases | 1 | 2023 | 244 | 0.210 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 2 | 2011 | 64 | 0.200 |
Why?
|
Cardiac Imaging Techniques | 1 | 2023 | 269 | 0.190 |
Why?
|
Early Growth Response Transcription Factors | 1 | 2020 | 29 | 0.190 |
Why?
|
Heart Failure | 3 | 2022 | 10900 | 0.190 |
Why?
|
Antigens, Human Platelet | 1 | 2020 | 43 | 0.180 |
Why?
|
Apolipoprotein A-I | 1 | 2021 | 281 | 0.180 |
Why?
|
Apolipoproteins B | 1 | 2021 | 374 | 0.170 |
Why?
|
T-Lymphocytes | 3 | 2011 | 10180 | 0.170 |
Why?
|
Interleukin-1 | 1 | 2023 | 1263 | 0.170 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.170 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2021 | 357 | 0.170 |
Why?
|
Running | 1 | 2023 | 480 | 0.160 |
Why?
|
Calcium | 2 | 2023 | 5756 | 0.160 |
Why?
|
Lymphopoiesis | 1 | 2009 | 135 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 551 | 0.160 |
Why?
|
Microcirculation | 1 | 2023 | 1286 | 0.160 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 504 | 0.150 |
Why?
|
Viremia | 1 | 2020 | 736 | 0.150 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2020 | 641 | 0.150 |
Why?
|
Dermatitis, Atopic | 1 | 2024 | 654 | 0.140 |
Why?
|
Troponin | 1 | 2020 | 524 | 0.140 |
Why?
|
Vasodilator Agents | 1 | 2021 | 977 | 0.140 |
Why?
|
Cell Differentiation | 3 | 2011 | 11483 | 0.140 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2020 | 233 | 0.140 |
Why?
|
Predictive Value of Tests | 2 | 2023 | 15076 | 0.130 |
Why?
|
Risk Factors | 7 | 2024 | 72290 | 0.130 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 2988 | 0.130 |
Why?
|
Fatty Liver | 1 | 2020 | 727 | 0.120 |
Why?
|
Clinical Medicine | 1 | 2015 | 147 | 0.120 |
Why?
|
Myeloid Cells | 1 | 2009 | 810 | 0.120 |
Why?
|
Aspirin | 2 | 2023 | 3282 | 0.120 |
Why?
|
Prospective Studies | 4 | 2022 | 53288 | 0.120 |
Why?
|
Ischemia | 1 | 2023 | 1907 | 0.120 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2282 | 0.110 |
Why?
|
Triglycerides | 1 | 2021 | 2454 | 0.110 |
Why?
|
History, 19th Century | 1 | 2015 | 720 | 0.110 |
Why?
|
Female | 15 | 2023 | 380194 | 0.110 |
Why?
|
Toll-Like Receptors | 1 | 2006 | 592 | 0.110 |
Why?
|
Treatment Outcome | 4 | 2024 | 63114 | 0.110 |
Why?
|
Autoantigens | 1 | 2006 | 892 | 0.100 |
Why?
|
Cholesterol | 1 | 2021 | 2917 | 0.100 |
Why?
|
Autoantibodies | 1 | 2020 | 2035 | 0.100 |
Why?
|
Recurrence | 1 | 2023 | 8340 | 0.100 |
Why?
|
Receptor, Notch1 | 2 | 2011 | 502 | 0.100 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1671 | 0.100 |
Why?
|
Hypertension | 2 | 2022 | 8480 | 0.100 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2011 | 147 | 0.100 |
Why?
|
Myeloid Progenitor Cells | 1 | 2011 | 111 | 0.100 |
Why?
|
Coronary Angiography | 1 | 2023 | 4577 | 0.100 |
Why?
|
Retrospective Studies | 5 | 2024 | 77449 | 0.090 |
Why?
|
Multipotent Stem Cells | 1 | 2011 | 186 | 0.090 |
Why?
|
Male | 16 | 2024 | 350118 | 0.090 |
Why?
|
Genes, Essential | 1 | 2011 | 183 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3778 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2073 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 2 | 2022 | 20129 | 0.080 |
Why?
|
Pain | 1 | 2023 | 4986 | 0.080 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2011 | 491 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 3068 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12354 | 0.070 |
Why?
|
B-Cell Activating Factor | 1 | 2007 | 119 | 0.070 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1177 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3864 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10388 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9146 | 0.070 |
Why?
|
Registries | 1 | 2022 | 8089 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2968 | 0.070 |
Why?
|
B-Lymphocyte Subsets | 1 | 2007 | 246 | 0.070 |
Why?
|
Alternative Splicing | 1 | 2011 | 1117 | 0.070 |
Why?
|
Aged | 4 | 2021 | 163280 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 21827 | 0.070 |
Why?
|
Hospitalization | 2 | 2021 | 10262 | 0.060 |
Why?
|
Cohort Studies | 3 | 2022 | 40561 | 0.060 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2007 | 548 | 0.060 |
Why?
|
Prognosis | 2 | 2022 | 29063 | 0.060 |
Why?
|
Risk Assessment | 2 | 2024 | 23338 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9959 | 0.060 |
Why?
|
Middle Aged | 7 | 2022 | 213383 | 0.060 |
Why?
|
Up-Regulation | 1 | 2011 | 4217 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2011 | 4204 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1903 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2011 | 2866 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29144 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2009 | 18029 | 0.050 |
Why?
|
Spleen | 1 | 2007 | 2362 | 0.050 |
Why?
|
Bone Marrow | 1 | 2011 | 2948 | 0.050 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2020 | 44 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 4026 | 0.050 |
Why?
|
Intubation | 1 | 2020 | 141 | 0.050 |
Why?
|
B-Lymphocytes | 2 | 2009 | 4665 | 0.050 |
Why?
|
Mice | 8 | 2020 | 81183 | 0.040 |
Why?
|
Pipecolic Acids | 1 | 2020 | 76 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2020 | 130 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 132 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 435 | 0.040 |
Why?
|
Vaccination | 2 | 2022 | 3278 | 0.040 |
Why?
|
Child, Preschool | 1 | 2022 | 41006 | 0.040 |
Why?
|
Culture Media, Serum-Free | 1 | 2009 | 158 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1360 | 0.040 |
Why?
|
Stroke Volume | 2 | 2022 | 5007 | 0.040 |
Why?
|
Young Adult | 2 | 2022 | 56430 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12745 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2020 | 14557 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4751 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4462 | 0.040 |
Why?
|
Drug Substitution | 1 | 2020 | 281 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2020 | 19229 | 0.040 |
Why?
|
Antibody Formation | 1 | 2022 | 1402 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1656 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2020 | 314 | 0.040 |
Why?
|
Coronary Thrombosis | 1 | 2020 | 495 | 0.040 |
Why?
|
Fibrosis | 1 | 2023 | 2029 | 0.040 |
Why?
|
Arginine | 1 | 2020 | 944 | 0.040 |
Why?
|
Antigens, CD19 | 1 | 2009 | 380 | 0.030 |
Why?
|
Thymus Gland | 2 | 2011 | 1267 | 0.030 |
Why?
|
Animals | 11 | 2020 | 168757 | 0.030 |
Why?
|
Birds | 1 | 1976 | 163 | 0.030 |
Why?
|
Cecum | 1 | 1976 | 237 | 0.030 |
Why?
|
Thrombectomy | 1 | 2020 | 680 | 0.030 |
Why?
|
Antibodies, Antinuclear | 1 | 2006 | 326 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2011 | 5974 | 0.030 |
Why?
|
Shock, Cardiogenic | 1 | 2020 | 688 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2618 | 0.030 |
Why?
|
Nucleic Acids | 1 | 2006 | 182 | 0.030 |
Why?
|
Models, Immunological | 1 | 2006 | 527 | 0.030 |
Why?
|
Signal Transduction | 2 | 2020 | 23403 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5078 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5179 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2006 | 973 | 0.030 |
Why?
|
Viral Load | 1 | 2020 | 3299 | 0.030 |
Why?
|
Warfarin | 1 | 2020 | 1496 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3870 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2759 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3176 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2161 | 0.020 |
Why?
|
NADP | 3 | 1975 | 226 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1938 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2011 | 13033 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4560 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2011 | 821 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6489 | 0.020 |
Why?
|
Liver | 2 | 2020 | 7474 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3279 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3218 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 12072 | 0.020 |
Why?
|
Paraneoplastic Syndromes | 1 | 1979 | 151 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2011 | 5524 | 0.020 |
Why?
|
Stents | 1 | 2020 | 3280 | 0.020 |
Why?
|
Vasopressins | 1 | 1979 | 370 | 0.020 |
Why?
|
Adult | 4 | 2024 | 214055 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8642 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1979 | 648 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7186 | 0.020 |
Why?
|
Mitochondria | 1 | 2020 | 3520 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3670 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2006 | 2258 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 805 | 0.020 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 407 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12026 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1655 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2011 | 1730 | 0.020 |
Why?
|
Digitoxin | 1 | 1975 | 22 | 0.020 |
Why?
|
Glutamate Dehydrogenase | 1 | 1975 | 52 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13989 | 0.020 |
Why?
|
Microsomes, Liver | 1 | 1975 | 173 | 0.020 |
Why?
|
Ifosfamide | 1 | 1975 | 228 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2023 | 15540 | 0.020 |
Why?
|
Exons | 1 | 2011 | 2437 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2007 | 793 | 0.020 |
Why?
|
Carcinosarcoma | 1 | 1975 | 108 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18370 | 0.010 |
Why?
|
Urea | 1 | 1975 | 450 | 0.010 |
Why?
|
Calcium Signaling | 1 | 2007 | 721 | 0.010 |
Why?
|
NAD | 1 | 1975 | 593 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6171 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12797 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1975 | 2242 | 0.010 |
Why?
|
Immunity | 1 | 1975 | 1012 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.010 |
Why?
|
Carcinoma | 1 | 1979 | 2375 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 18111 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 15997 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10481 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
Propionates | 1 | 1976 | 169 | 0.010 |
Why?
|
Fatty Acids, Volatile | 1 | 1976 | 102 | 0.010 |
Why?
|
Butyrates | 1 | 1976 | 163 | 0.010 |
Why?
|
Acetates | 1 | 1976 | 311 | 0.010 |
Why?
|
United States | 1 | 2020 | 69872 | 0.010 |
Why?
|
Species Specificity | 1 | 1976 | 2478 | 0.010 |
Why?
|
APUD Cells | 1 | 1979 | 6 | 0.010 |
Why?
|
Adrenocortical Hyperfunction | 1 | 1979 | 14 | 0.010 |
Why?
|
Inappropriate ADH Syndrome | 1 | 1979 | 61 | 0.010 |
Why?
|
Water-Electrolyte Imbalance | 1 | 1979 | 113 | 0.010 |
Why?
|
Digitoxigenin | 1 | 1975 | 11 | 0.000 |
Why?
|
Lethal Dose 50 | 1 | 1975 | 77 | 0.000 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1975 | 220 | 0.000 |
Why?
|
Chromatography, Thin Layer | 1 | 1975 | 223 | 0.000 |
Why?
|
Hydroxylation | 1 | 1975 | 141 | 0.000 |
Why?
|
Stimulation, Chemical | 1 | 1975 | 326 | 0.000 |
Why?
|
Ketoglutaric Acids | 1 | 1975 | 78 | 0.000 |
Why?
|
Erythrocyte Count | 1 | 1975 | 163 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1979 | 13102 | 0.000 |
Why?
|
Fourier Analysis | 1 | 1975 | 447 | 0.000 |
Why?
|
Energy Metabolism | 1 | 1976 | 2899 | 0.000 |
Why?
|
Molecular Conformation | 1 | 1975 | 563 | 0.000 |
Why?
|
Drug Tolerance | 1 | 1975 | 376 | 0.000 |
Why?
|
Spectrometry, Fluorescence | 1 | 1975 | 689 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1975 | 13695 | 0.000 |
Why?
|
Sex Factors | 1 | 1976 | 10397 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1975 | 1588 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1975 | 2557 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1975 | 2187 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1975 | 1276 | 0.000 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1975 | 1375 | 0.000 |
Why?
|
Structure-Activity Relationship | 1 | 1975 | 3129 | 0.000 |
Why?
|
Cattle | 1 | 1975 | 3922 | 0.000 |
Why?
|
Temperature | 1 | 1975 | 2206 | 0.000 |
Why?
|
Rats | 2 | 1975 | 24260 | 0.000 |
Why?
|
Kinetics | 1 | 1975 | 6473 | 0.000 |
Why?
|
Diet | 1 | 1976 | 7939 | 0.000 |
Why?
|
Hyperglycemia | 1 | 1975 | 1373 | 0.000 |
Why?
|
Models, Molecular | 1 | 1975 | 5456 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1975 | 3760 | 0.000 |
Why?
|
Time Factors | 2 | 1975 | 40075 | 0.000 |
Why?
|